Adverum
Showing 1 - 8 of 8
Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
Enrolling by invitation
- Diabetic Macular Edema
- Diabetic Retinopathy
- ADVM-022
-
Beverly Hills, California
- +6 more
Nov 4, 2022
Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)
Recruiting
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Phoenix, Arizona
- +4 more
Sep 8, 2022
Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)
Active, not recruiting
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Bakersfield, California
- +10 more
Mar 21, 2022
Diabetic Macular Edema, Diabetic Retinopathy Trial in Puerto Rico, United States (6E11 vg/eye of ADVM-022, 2E11 vg/eye of
Active, not recruiting
- Diabetic Macular Edema
- Diabetic Retinopathy
- 6E11 vg/eye of ADVM-022
- +2 more
-
Phoenix, Arizona
- +13 more
Jan 10, 2022
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
Enrolling by invitation
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Bakersfield, California
- +8 more
Dec 23, 2021
Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)
Completed
- Alpha 1-Antitrypsin Deficiency
- ADVM-043
-
Gainesville, Florida
- +1 more
Aug 3, 2022
Friedreich's Ataxia Trial in Paris (Cardiac magnetic resonance imaging (CMR), Exercise-stress test, Echocardiography (ECHO))
Completed
- Friedreich's Ataxia
- Cardiac magnetic resonance imaging (CMR)
- +3 more
-
Paris, FranceHôpital Pitié-Salpêtrière, AP-HP
Dec 7, 2018
Macular Degeneration, Age-related Maculopathies, Age-related Maculopathy Trial in Nedlands (rAAV.sFlt-1, Control (ranibizumab
Completed
- Macular Degeneration
- +7 more
- rAAV.sFlt-1
- Control (ranibizumab alone)
-
Nedlands, Western Australia, AustraliaLions Eye Institute
Aug 30, 2017